Previous 10 | Next 10 |
Verde Clean Fuels Inc. (VGAS) is expected to report for Q4 2023 Pioneer Bancorp Inc. (PBFS) is expected to report for Q2 2024 Equity Commonwealth of Beneficial Interest (EQC) is expected to report $0.27 for Q4 2023 monday.com Ltd. (MNDY) is expected to report $-0.31 for Q4 2023 As...
BioStem Technologies Inc (BSEM) is expected to report $0.47 for Q4 2023
BioStem provides a business update and highlights recent accomplishments Preliminary fourth quarter net revenues of $11.5 million and full year 2023 net revenues of $16.7 million National Pricing for Amniowrap2™ effective January 1 st in all 50 states and territories POMP...
POMPANO BEACH, Fla., Jan. 11, 2024 (GLOBE NEWSWIRE) -- BioStem Technologies Inc . (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, today announces it has appointed a ...
POMPANO BEACH, Fla., Dec. 19, 2023 (GLOBE NEWSWIRE) -- BioStem Technologies Inc . (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, today announces it has appointed Mr...
POMPANO BEACH, Fla., Dec. 14, 2023 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics for advanced wound care, announced that the Center for Medicare Servi...
POMPANO BEACH, Fla., Dec. 13, 2023 (GLOBE NEWSWIRE) -- BioStem Technologies Inc . (OTC:BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, today announces the appointment of M...
2023-11-14 10:58:43 ET BioStem Technologies press release ( OTCPK:BSEM ): Q3 GAAP EPS of $0.03. Revenue of $3.6M (+227.3% Y/Y). For further details see: BioStem Technologies GAAP EPS of $0.03, revenue of $3.6M
POMPANO BEACH, Fla., Nov. 13, 2023 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics, today reported financial results for the quarter ended September 30,...
POMPANO BEACH, Fla., Nov. 08, 2023 (GLOBE NEWSWIRE) -- BioStem Technologies Inc . (OTC:BSEM), a leading regenerative medicine company focused on the development, manufacture and commercialization of placental-derived biologics for advanced wound care, today announced that the Centers for ...
News, Short Squeeze, Breakout and More Instantly...
BioStem Technologies Inc Company Name:
BSEM Stock Symbol:
OTCMKTS Market:
BioStem Technologies Inc Website:
Miami, Florida--(Newsfile Corp. - July 16, 2024) - Innovation is the lifeblood of the MedTech sector. Literally. Discoveries made are more than value drivers for the companies behind them; they can be life savers to millions needing better and more effective healthcare solutions. While that need ...
POMPANO BEACH, Fla., July 10, 2024 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, announces that the IRB has approved a clinic...
POMPANO BEACH, Fla., June 26, 2024 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived allografts for advanced wound care, today announced that an article validating ...